Portage’s Biohaven Acquires Intellectual Property for Portfolio of Prodrugs from ALS Biopharma, LLC Press ReleaseBy Portage Biotech, IncAugust 18, 2015...
Portage’s Biohaven Raises US$4.1 Million in First Tranche of Private Placement. Portage Invests $2.5M Press ReleaseBy Portage Biotech, IncAugust 11, 2015...
Portage Invests in Sentien Biotechnologies, Inc. Press ReleaseBy Portage Biotech, IncAugust 10, 2015...
Portage’s Biohaven Announces IND Filing for BHV-0223 for Phase I Clinical Testing Press ReleaseBy Portage Biotech, IncJuly 23, 2015...
Portage Completes Non-Brokered Private Placement in Two Tranches for Total Proceeds of US$ 5,155,080 Press ReleaseBy Portage Biotech, IncJune 25, 2015...
Portage Closes First Tranche of Private Placement Press ReleaseBy Portage Biotech, IncJune 16, 2015...
Portage’s Biohaven to Begin Phase I Study in 3Q 2015 and Readying for Phase III Study Start by Q1 2016 Press ReleaseBy Portage Biotech, IncApril 22, 2015...
Portage’s CPP Platform Delivers a Peptide Cargo Across the Blood Brain Barrier Press ReleaseBy Portage Biotech, IncApril 20, 2015...
Portage’s Biohaven Announces Agreement with Inventiv Health Press ReleaseBy Portage Biotech, IncApril 1, 2015...
